Skip to content
  • Access/Contact
  • JP
  • Members Only

Institute for Vaccine Research and Development(IVReD), Institute for Integrated Innovations

  • Career
  • About Us
  • Message from Director
  • Organization
  • Public Relations
  • Division of Vaccine Development
  • Division of Biological Response Analysis
  • Division of Vaccinology for Clinical Development
  • Division of Research Support
  • Advisor to the Director
  • Our Members
  • Sawa Laboratory
  • Matsuo Laboratory
  • New Achievement
  • Publications -FY2025-
    • Publications -FY2024-
    • Publications -FY2023-
    • Publications -FY2022-
  • Latest Rumor Surveillance
  • Information as of May 25, 2026
  • Information as of May 14, 2026
  • Information as of May 4, 2026
  • Information as of Aprl 23, 2026
  • Information as of March 16, 2026
  • Information as of March 3, 2026
  • Rumor Surveillance 2025-2026
  • Rumor Surveillance 2023-2024

New Achievement

    • Highly pathogenic avian influenza virus (HPAIV)
    Evaluation of the Efficacy of Low-Concentration Gaseous Chlorine Dioxide in Inactivating Airborne H5 High Pathogenicity Avian Influenza Virus in Vivo Model
    Jun 04, 2026
    • probiotics
    Enhancement of Vaccine-Induced T-Cell Responses by Probiotics in Calves
    Oct 31, 2025
    • IgA
    • Zirconia Particles
    Purification of Immunoglobulin A Using Mesoporous Zirconia Particles Coated with Phosphate
    Aug 29, 2025
Show List
Back to top
  • Share by Facebook
  • Share by Twitter
  • Share by LINE
  • Access/Contact
  • Site Policy
  • Members Only
Institute for Vaccine Research and Development(IVReD), Institute for Integrated Innovations

We use cookies to improve our website for users' usability and experience. To accept cookies, click “Accept”.